Kopp Investment Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
GIP
EMFAT
Kopp Investment Advisors's NEO Position: Q3 2019 in Review
Kopp Investment Advisors reduced its NeoGenomics (NEO) stake by 37% in Q3 2019, selling an estimated $2.81M and leaving 207,781 shares worth $3.97M. The position accounts for 7.3% of the portfolio, ranked #1.
Kopp Investment Advisors first reported a position in NEO in Q2 2013 and has held it in 26 quarters since. The position peaked at $12.3M in Q4 2015. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.
- Kopp Investment Advisors held 207,781 shares of NeoGenomics worth $3.97M as of Q3 2019.
- Kopp Investment Advisors sold 119,657 NeoGenomics shares in Q3 2019, an estimated $2.81M.
- NeoGenomics made up 7.3% of Kopp Investment Advisors's portfolio in Q3 2019, its #1 holding.
- Kopp Investment Advisors first reported a position in NeoGenomics in Q2 2013 and has held it in 26 quarters since.
- Kopp Investment Advisors's NeoGenomics position peaked at $12.3M in Q4 2015.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.
Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.